Ritter Allen R

Avg. Two Year Performance

No purchase track record

71% Avg. Sale Return

31% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	27%	45%	31%	48%	71%
Sale Success Rate	6 of 8	2 of 8	4 of 8	4 of 8	8 of 8

Endocyte, Inc.

Drugs » Drug Manufacturers - Major

VP of Manufacturing/CMC:

Holdings: 34.28K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--